XVIVOS Biosciences

XVIVOS Biosciences has developed a personalized, digital cognitive assessment test (NeuroBlot) which replaces the current standard of pen-and-paper memory tests that are delivered as a first-line diagnostic tool for acute or chronic cognitive decline. NeuroBlot scans your social media accounts to create personalized memory tasks, assessing your cognitive capacity based on your unique content and across multiple media formats (e.g. text, images, video, audio). NeuroBlot anticipates an individual’s risk of cognitive decline, generating actionable insights for primary care providers and reducing the financial burden on the healthcare system by saving doctors’ and patients’ time.

Contact: saumel.ahmadi@mail.utoronto.ca

Website: http://www.xvivos.com/